ADIPOQ and Hyperglycemia: Compared to people without diabetes, patients with diabetes are often accompanied by more risk factors, such as adiponectin gene variation, obesity, hyperglycemia, oxidative stress, and unhealthy lifestyle, all of which inhibit the expression and secretion of adiponectin [23–25].